ZA201407335B - Injectable preparation - Google Patents

Injectable preparation

Info

Publication number
ZA201407335B
ZA201407335B ZA2014/07335A ZA201407335A ZA201407335B ZA 201407335 B ZA201407335 B ZA 201407335B ZA 2014/07335 A ZA2014/07335 A ZA 2014/07335A ZA 201407335 A ZA201407335 A ZA 201407335A ZA 201407335 B ZA201407335 B ZA 201407335B
Authority
ZA
South Africa
Prior art keywords
injectable preparation
injectable
preparation
Prior art date
Application number
ZA2014/07335A
Other languages
English (en)
Inventor
Matsuda Takakuni
Kaneko Daiki
Hoshika Yusuke
Original Assignee
Otsuka Pharmaceutical Co Ltd A Company Incorporated In Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=48614096&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201407335(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Otsuka Pharmaceutical Co Ltd A Company Incorporated In Japan filed Critical Otsuka Pharmaceutical Co Ltd A Company Incorporated In Japan
Publication of ZA201407335B publication Critical patent/ZA201407335B/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Inorganic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Psychiatry (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2014/07335A 2012-04-23 2014-10-09 Injectable preparation ZA201407335B (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261636938P 2012-04-23 2012-04-23
US201361792089P 2013-03-15 2013-03-15
PCT/JP2013/062683 WO2013162048A1 (en) 2012-04-23 2013-04-23 Injectable preparation

Publications (1)

Publication Number Publication Date
ZA201407335B true ZA201407335B (en) 2019-06-26

Family

ID=48614096

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/07335A ZA201407335B (en) 2012-04-23 2014-10-09 Injectable preparation

Country Status (31)

Country Link
US (9) US20150093442A1 (cg-RX-API-DMAC7.html)
EP (2) EP3539534A1 (cg-RX-API-DMAC7.html)
JP (7) JP6234996B2 (cg-RX-API-DMAC7.html)
KR (4) KR20240068788A (cg-RX-API-DMAC7.html)
CN (3) CN108186556B (cg-RX-API-DMAC7.html)
AR (1) AR090776A1 (cg-RX-API-DMAC7.html)
AU (6) AU2013253374B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014026307B1 (cg-RX-API-DMAC7.html)
CA (2) CA2869889C (cg-RX-API-DMAC7.html)
CO (1) CO7151500A2 (cg-RX-API-DMAC7.html)
CY (1) CY1122252T1 (cg-RX-API-DMAC7.html)
DK (1) DK2841054T4 (cg-RX-API-DMAC7.html)
EA (1) EA026619B1 (cg-RX-API-DMAC7.html)
ES (1) ES2743706T5 (cg-RX-API-DMAC7.html)
HR (1) HRP20191366T4 (cg-RX-API-DMAC7.html)
HU (1) HUE045979T2 (cg-RX-API-DMAC7.html)
IL (1) IL235299B (cg-RX-API-DMAC7.html)
JO (2) JOP20200109A1 (cg-RX-API-DMAC7.html)
LT (1) LT2841054T (cg-RX-API-DMAC7.html)
MX (2) MX359241B (cg-RX-API-DMAC7.html)
MY (3) MY210484A (cg-RX-API-DMAC7.html)
NZ (1) NZ630335A (cg-RX-API-DMAC7.html)
PH (2) PH12014502379B1 (cg-RX-API-DMAC7.html)
PL (1) PL2841054T5 (cg-RX-API-DMAC7.html)
PT (1) PT2841054T (cg-RX-API-DMAC7.html)
SG (3) SG11201406451SA (cg-RX-API-DMAC7.html)
SI (1) SI2841054T2 (cg-RX-API-DMAC7.html)
TW (6) TW202126303A (cg-RX-API-DMAC7.html)
UA (1) UA115444C2 (cg-RX-API-DMAC7.html)
WO (1) WO2013162048A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201407335B (cg-RX-API-DMAC7.html)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR090775A1 (es) 2012-04-23 2014-12-03 Otsuka Pharma Co Ltd Preparado inyectable
JOP20200109A1 (ar) 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
TWI562991B (en) * 2012-04-23 2016-12-21 Otsuka Pharma Co Ltd Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same
CN105461703B (zh) * 2014-12-29 2019-05-17 深圳市泛谷药业股份有限公司 一种brexpiprazole的制备方法
JP6513461B2 (ja) * 2015-04-14 2019-05-15 帝國製薬株式会社 ブレクスピプラゾールの経皮吸収製剤
CN104829603A (zh) * 2015-05-19 2015-08-12 杭州新博思生物医药有限公司 A晶型依匹唑派盐酸盐及其制备方法
WO2017134038A1 (en) * 2016-02-01 2017-08-10 Hexal Ag Anhydrate-free polymorphically pure micronized crystalline brexpiprazole dihydrate for use in intramuscular injectable sustained release formulations
US11235976B2 (en) * 2017-01-26 2022-02-01 Sichuan Yingrui Pharmaceutical Technology Company Nanocarbon-iron composite system as well as composition, preparation method and use thereof
US10987303B2 (en) 2018-05-02 2021-04-27 LifeMax Laboratories, Inc. Extended release suspension formulation of lurasidone
WO2020089942A2 (en) * 2018-11-02 2020-05-07 Amaterasu Lifesciences Llp A liquid injectable composition
WO2021199076A1 (en) * 2020-03-30 2021-10-07 Cipla Limited Injectable aripiprazole formulation
PL4125903T3 (pl) * 2020-04-01 2025-02-03 Otsuka Pharmaceutical Co., Ltd. Sposoby rozpoczynania podawania leczenia arypiprazolem
US20230372317A1 (en) * 2020-10-27 2023-11-23 Pts Consulting, Llc A liquid injectable composition of donepezil
US11229644B1 (en) * 2020-12-31 2022-01-25 Lake O'hara Llc Methods of treating psychiatric disorders in obese patients with brexpiprazole
US11910794B2 (en) 2021-03-08 2024-02-27 Monsanto Technology Llc Solutions and methods for long-term pollen storage
WO2023067664A1 (ja) * 2021-10-18 2023-04-27 大塚製薬株式会社 ベンゾチオフェン化合物の新規結晶形及びその製造方法
JP7760615B2 (ja) * 2022-06-16 2025-10-27 ウィズダム・ファーマスーティカル・カンパニー・リミテッド 薬物組成物及びブレクスピプラゾール口腔内溶解フィルム
CN115969785A (zh) * 2022-12-30 2023-04-18 辰欣药业股份有限公司 一种阿立哌唑注射剂及其制备方法
CA3197997A1 (en) * 2023-03-17 2025-01-23 Otsuka Pharmaceutical Co., Ltd. METHODS FOR DISPERSING INJECTABLE PREPARATIONS OF ARIPIPRAZOLE
TW202448470A (zh) 2023-04-26 2024-12-16 日商大塚製藥股份有限公司 用於以阿立哌唑治療思覺失調症或第一型雙極性疾患之劑量起始
WO2025051281A1 (zh) * 2023-09-08 2025-03-13 广州玻思韬控释药业有限公司 注射用依匹哌唑凝胶
WO2025183016A1 (ja) * 2024-02-26 2025-09-04 大塚製薬株式会社 Ｑｕａｂｏｄｅｐｉｓｔａｔ含有組成物

Family Cites Families (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB864100A (en) * 1957-04-09 1961-03-29 Pfizer & Co C Therapeutic pencillin compositions and the preparation thereof
JPS5913714A (ja) 1982-07-13 1984-01-24 Taito Pfizer Kk 外用消炎鎮痛剤
US5006528A (en) 1988-10-31 1991-04-09 Otsuka Pharmaceutical Co., Ltd. Carbostyril derivatives
US5192802A (en) 1991-09-25 1993-03-09 Mcneil-Ppc, Inc. Bioadhesive pharmaceutical carrier
JP4012994B2 (ja) 1996-05-08 2007-11-28 大塚製薬株式会社 抗不安薬
US20020076437A1 (en) 2000-04-12 2002-06-20 Sanjeev Kothari Flashmelt oral dosage formulation
US6495164B1 (en) 2000-05-25 2002-12-17 Alkermes Controlled Therapeutics, Inc. I Preparation of injectable suspensions having improved injectability
AR032641A1 (es) 2001-01-29 2003-11-19 Otsuka Pharma Co Ltd Agonista de subtipo de receptor 5-ht 1a.
MY129350A (en) 2001-04-25 2007-03-30 Bristol Myers Squibb Co Aripiprazole oral solution
PE20030445A1 (es) * 2001-09-25 2003-07-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
AR033485A1 (es) 2001-09-25 2003-12-26 Otsuka Pharma Co Ltd Sustancia medicinal de aripiprazol de baja higroscopicidad y proceso para la preparacion de la misma
JP2003171264A (ja) * 2001-12-07 2003-06-17 Taiyo Yakuhin Kogyo Kk マイクロカプセル及びその製造方法
JP2003238393A (ja) 2002-02-15 2003-08-27 Otsuka Pharmaceut Co Ltd 施錠性が改善された錠剤及びその製造方法
HRP20050149B1 (hr) * 2002-08-20 2014-09-12 Otsuka Pharmaceutical Co., Ltd. Formulacija aripiprazol kompleksa i postupak
CN1989968B (zh) 2002-12-27 2011-05-11 大塚制药株式会社 用于治疗情绪障碍的喹诺酮衍生物和5-羟色胺再摄取抑制剂
DE60302139T3 (de) 2003-01-09 2011-02-24 Otsuka Pharmaceutical Co., Ltd. Verfahren zur herstellung von aripiprazole
WO2004064752A2 (en) 2003-01-22 2004-08-05 Alkermes Controlled Therapeutics, Inc. Method of preparing sustained release microparticles
CA2523484A1 (en) * 2003-05-02 2004-11-11 Rimon Therapeutics Ltd. Thermally reversible implant
MXPA05012538A (es) 2003-05-23 2006-02-22 Otsuka Pharma Co Ltd Derivados de carbostirilo y estabilizantes del estado de animo para trastornos del mismo.
US6987111B2 (en) 2003-08-06 2006-01-17 Alkermes Controlled Therapeutics, Ii Aripiprazole, olanzapine and haloperidol pamoate salts
US20050032811A1 (en) 2003-08-06 2005-02-10 Josiah Brown Methods for administering aripiprazole
TWI371274B (en) 2003-10-23 2012-09-01 Bristol Myers Squibb Co Process for making sterile aripiprazole of desired mean particle size
JP4836797B2 (ja) 2003-10-23 2011-12-14 大塚製薬株式会社 放出制御性無菌注射アリピプラゾール製剤および方法
CN1893931B (zh) 2003-10-27 2011-07-20 陶氏康宁公司 局部用制剂及将活性剂传递给基底的方法
EP2633853A1 (en) 2004-01-12 2013-09-04 The Trustees of The University of Pennsylvania Long-term delivery formulations and methods of use thereof
JP2006219380A (ja) * 2005-02-08 2006-08-24 Minofuaagen Seiyaku:Kk グリチルリチン皮下注射製剤
TWI320783B (en) 2005-04-14 2010-02-21 Otsuka Pharma Co Ltd Heterocyclic compound
CA2622758A1 (en) 2005-09-15 2007-03-29 Elan Pharma International, Limited Nanoparticulate aripiprazole formulations
ES2437581T3 (es) 2005-11-17 2014-01-13 Zogenix, Inc. Suministro de formulaciones viscosas por inyección sin aguja
JP4373983B2 (ja) 2006-01-27 2009-11-25 三菱電機インフォメーションシステムズ株式会社 流通経路管理装置及び流通経路管理プログラム
GB0618879D0 (en) * 2006-09-26 2006-11-01 Zysis Ltd Pharmaceutical compositions
KR20090087441A (ko) * 2006-10-05 2009-08-17 파나세아 바이오테크 리미티드 새로운 형태의 주입형 데포 조성물 및 이를 위한 조제방법
JP4540700B2 (ja) 2006-10-13 2010-09-08 大塚製薬株式会社 医薬
US20100151459A1 (en) 2007-01-26 2010-06-17 Jun Soo Kwon Marker for detecting the proposed efficacy of treatment
EP2170300B1 (en) 2007-06-25 2014-12-31 Otsuka Pharmaceutical Co., Ltd. Microspheres having core/shell structure
MX2010001311A (es) 2007-07-31 2010-04-21 Otsuka Pharma Co Ltd Metodo para producir una suspensi?n de aripiprazol y formulacion liofilizada.
WO2009026473A2 (en) * 2007-08-21 2009-02-26 Hollis-Eden Pharmaceuticals, Inc. Stabilized therapeutic compositions and formulations
JP2011136906A (ja) * 2008-04-18 2011-07-14 Otsuka Pharmaceut Co Ltd 複素環化合物
JP2009286740A (ja) 2008-05-30 2009-12-10 Otsuka Pharmaceut Co Ltd アリピプラゾールを含有する逆耐性抑制剤
TR200809200A1 (tr) 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
US20100316725A1 (en) 2009-05-27 2010-12-16 Elan Pharma International Ltd. Reduction of flake-like aggregation in nanoparticulate active agent compositions
SG178938A1 (en) 2009-09-11 2012-04-27 Otsuka Pharma Co Ltd Therapeutic agent for chronic pain
MX344235B (es) * 2010-08-24 2016-12-07 Otsuka Pharmaceutical Co Ltd * Suspension y composicion en torta que contiene un derivado de carbostirilo y aceite de silicona y/o un derivado de aceite de silicona.
JP5893616B2 (ja) * 2010-10-18 2016-03-23 大日本住友製薬株式会社 注射用徐放性製剤
AR083884A1 (es) 2010-11-16 2013-03-27 Otsuka Pharma Co Ltd Jeringa prellenable de doble camara y relleno de aripiprazol en la jeringa
JP2012121850A (ja) 2010-12-09 2012-06-28 Otsuka Pharmaceut Co Ltd アリピプラゾールの経口速溶性組成物
DK2667856T3 (da) 2011-01-24 2021-08-30 Otsuka Pharma Co Ltd Medicinsk indretning indeholdende en tørstofsammensætning omfattende aripiprazol som en aktiv ingrediens, og en tørstofsammensætning omfattende aripiprazol som en aktiv ingrediens
TWI636784B (zh) 2011-04-05 2018-10-01 大塚製藥股份有限公司 含7-〔4-(4-苯並〔b〕噻吩-4-基-哌-1-基)丁氧基〕-1H-喹啉-2-酮之醫藥組成物與套組，以及彼之用途
JP2012232958A (ja) † 2011-05-09 2012-11-29 Otsuka Pharmaceut Co Ltd 注射製剤
JO3410B1 (ar) 2011-06-07 2019-10-20 Otsuka Pharma Co Ltd تركيبة أريبيبرازول مجفف بالتبريد
CN102846543B (zh) * 2011-06-27 2014-11-19 上海中西制药有限公司 一种阿立哌唑药物制剂及其制备方法
TW201309651A (zh) 2011-06-29 2013-03-01 Otsuka Pharma Co Ltd 阿立哌唑（ａｒｉｐｉｐｒａｚｏｌｅ）無水物Ｂ形結晶微粒子之製造方法
CN103717587B (zh) 2011-07-28 2016-02-10 大塚制药株式会社 制造苯并[b]噻吩化合物的方法
JO3227B1 (ar) 2011-09-08 2018-03-08 Otsuka Pharma Co Ltd مشتقات بنزو ثيوفين بها استبدال ببرازين كعوامل مضادة للذهان
JO3753B1 (ar) 2011-10-14 2021-01-31 Otsuka Pharma Co Ltd قرص يتألف من 7-[4-(4-بينزو[بي]ثيوفين-4-ايل-ببرازين-1-1ايل)بوتكسيل]-1اتش-كوينولين-2-وان أو ملح منه
JO3190B1 (ar) 2011-10-19 2018-03-08 Otsuka Pharma Co Ltd محلول للتناول عن طريق الفم
TW201332572A (zh) 2011-12-28 2013-08-16 Otsuka Pharma Co Ltd 具有經取代的β－環糊精之藥物製劑
JP2013139441A (ja) 2011-12-28 2013-07-18 Otsuka Pharmaceut Co Ltd マイクロスフェア
TW201343201A (zh) 2012-03-06 2013-11-01 Otsuka Pharma Co Ltd 持續釋放型口服固體製劑
AR090775A1 (es) 2012-04-23 2014-12-03 Otsuka Pharma Co Ltd Preparado inyectable
JOP20200109A1 (ar) * 2012-04-23 2017-06-16 Otsuka Pharma Co Ltd مستحضر قابل للحقن
TWI562991B (en) 2012-04-23 2016-12-21 Otsuka Pharma Co Ltd Dihydrate of benzothiophene compound or of a salt thereof, and process for producing the same

Also Published As

Publication number Publication date
ES2743706T3 (es) 2020-02-20
JP2019070028A (ja) 2019-05-09
PL2841054T5 (pl) 2022-07-18
US20180055941A1 (en) 2018-03-01
CA3120297A1 (en) 2013-10-31
US20210085794A1 (en) 2021-03-25
JOP20200109A1 (ar) 2017-06-16
US20190099494A1 (en) 2019-04-04
US20150093442A1 (en) 2015-04-02
EP3539534A1 (en) 2019-09-18
CY1122252T1 (el) 2020-11-25
MX2014012811A (es) 2015-05-07
SG11201406451SA (en) 2014-11-27
MX387891B (es) 2025-03-19
CN114344259B (zh) 2024-02-13
JP2023113806A (ja) 2023-08-16
TW202126303A (zh) 2021-07-16
SG10201608753UA (en) 2016-12-29
BR112014026307A2 (pt) 2017-06-27
PH12019500498A1 (en) 2020-03-02
CA2869889A1 (en) 2013-10-31
US11638757B2 (en) 2023-05-02
CN108186556A (zh) 2018-06-22
AU2017228608B2 (en) 2018-10-18
SI2841054T1 (sl) 2019-09-30
PH12014502379A1 (en) 2015-01-12
KR102498075B1 (ko) 2023-02-10
CN104470499A (zh) 2015-03-25
MY198007A (en) 2023-07-25
JP6470378B2 (ja) 2019-02-13
TWI637752B (zh) 2018-10-11
JP2025041805A (ja) 2025-03-26
JP6234996B2 (ja) 2017-11-22
KR20150003861A (ko) 2015-01-09
CN104470499B (zh) 2018-03-16
HK1257028A1 (zh) 2019-10-11
JO3632B1 (ar) 2020-08-27
HRP20191366T4 (hr) 2022-08-19
CA2869889C (en) 2021-07-20
AU2013253374A1 (en) 2014-10-23
HUE045979T2 (hu) 2020-01-28
LT2841054T (lt) 2019-09-10
BR112014026307B1 (pt) 2022-10-11
AU2019200060A1 (en) 2019-01-31
US20250121065A1 (en) 2025-04-17
AR090776A1 (es) 2014-12-03
SI2841054T2 (sl) 2022-05-31
KR20210116702A (ko) 2021-09-27
IL235299B (en) 2019-12-31
PH12014502379B1 (en) 2015-01-12
US20190336607A1 (en) 2019-11-07
AU2020204200A1 (en) 2020-07-16
US12016927B2 (en) 2024-06-25
US20200179517A1 (en) 2020-06-11
AU2017228608C1 (en) 2019-02-21
EP2841054B2 (en) 2022-04-06
JP7612758B2 (ja) 2025-01-14
TW201350136A (zh) 2013-12-16
AU2013253374B2 (en) 2017-06-15
AU2017228608A1 (en) 2017-10-05
UA115444C2 (uk) 2017-11-10
US10517951B2 (en) 2019-12-31
EA201491685A1 (ru) 2015-04-30
US20220096638A1 (en) 2022-03-31
TW202535396A (zh) 2025-09-16
JP2021008512A (ja) 2021-01-28
AU2022241491A1 (en) 2022-10-20
KR102138852B1 (ko) 2020-07-28
TWI713826B (zh) 2020-12-21
CO7151500A2 (es) 2014-12-29
PT2841054T (pt) 2019-09-09
CN114344259A (zh) 2022-04-15
TW202425992A (zh) 2024-07-01
JP2015514751A (ja) 2015-05-21
EP2841054B1 (en) 2019-06-26
MX359241B (es) 2018-09-20
SG10201913425VA (en) 2020-03-30
DK2841054T4 (da) 2022-06-13
ES2743706T5 (es) 2022-05-25
EP2841054A1 (en) 2015-03-04
TW202313036A (zh) 2023-04-01
HK1206988A1 (en) 2016-01-22
AU2022241491B2 (en) 2024-10-24
KR20240068788A (ko) 2024-05-17
IL235299A0 (en) 2014-12-31
EA026619B1 (ru) 2017-04-28
NZ630335A (en) 2016-07-29
MY178573A (en) 2020-10-16
JP2018048179A (ja) 2018-03-29
TW201900174A (zh) 2019-01-01
JP7293412B2 (ja) 2023-06-19
AU2025200229A1 (en) 2025-01-30
HRP20191366T1 (hr) 2019-12-27
US11097007B2 (en) 2021-08-24
MY210484A (en) 2025-09-24
PL2841054T3 (pl) 2019-10-31
JP2022050619A (ja) 2022-03-30
DK2841054T3 (da) 2019-09-09
CN108186556B (zh) 2022-06-10
AU2020204200B2 (en) 2022-06-30
WO2013162048A1 (en) 2013-10-31
US20230390399A1 (en) 2023-12-07
KR20200064173A (ko) 2020-06-05

Similar Documents

Publication Publication Date Title
IL235299A0 (en) Injectable preparation
DK3327112T3 (en) Agse-deficient stamme
GB201210082D0 (en) Improved syringe
EP2934531A4 (en) COMBINATION
IL235211A0 (en) Injectable preparation
EP2911673A4 (en) COMBINATION
EP2920142A4 (en) MÉTHANOFULLERRÈNES
ZA201406703B (en) Improved injections
GB2500883B (en) Improved saw-horse
EP2925728A4 (en) COMBINATION
GB2499853B (en) MicBooth
GB201210088D0 (en) Odontalgic preparation
ZA201305187B (en) Improved brattice
EP2908815A4 (en) COMBINATION
EP2908816A4 (en) ASSOCIATION
GB201216178D0 (en) Combination
AU345893S (en) Treehouse
GB201201767D0 (en) Pop-tops
GB201201668D0 (en) LOCnlatch
GB201201023D0 (en) Sharkbitze
GB201200939D0 (en) Drinc-pinc
GB201201085D0 (en) Hit-a-pair
GB201200644D0 (en) Visualiser
GB201200467D0 (en) Coda251
GB201200226D0 (en) Kinibra